CASI Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CASI for the last quarter is 6.09 M USD, and it's 40.63% lower compared to the previous quarter. The net income of Q4 23 is -5.46 M USD.